Comparison results
| Results: Differences General | ✘Chronic myeloid leukemia | ✘Tuberculosis of the eyes | |||||||
| Related research | Analogs | Analogs | |||||||
| |||||||||
| Distinctive symptoms | |||||||||
| Register, to see more distinctive signs of diseases and studies | 29% | — | |||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
| acute lymphoblastic leukemia | 28% | — | |||||||
| better in mountains | — | 91% | |||||||
| alcoholism | 27% | — | |||||||
| suffocating | — | 77% | |||||||
| chronic leukemia | 27% | — | |||||||
| tuberculosis of the eyes | — | 57% | |||||||
| alcohol dependence | 25% | — | |||||||
| bullous emphysema of the lung | — | 57% | |||||||
| lymphocytic | 25% | — | |||||||
| lung cyst | — | 54% | |||||||
| acute leukemia | 24% | — | |||||||
| blisters | — | 51% | |||||||
| aching | 24% | — | |||||||
| bronchial asthma | — | 48% | |||||||
| leukemia | 21% | — | |||||||
| inflammation | — | 47% | |||||||
| chronic lymphocytic | 21% | — | |||||||
| impressionability | — | 44% | |||||||
| thrombocytosis | 18% | — | |||||||
| visual impairment | — | 34% | |||||||
| leukocytosis | 16% | — | |||||||
| inflammation of the eyes | — | 34% | |||||||
| enlargement of the spleen | 15% | — | |||||||
| eye surgery | — | 34% | |||||||
| crystalluria | 13% | — | |||||||
| nose large eyes | — | 32% | |||||||
| feeling of bruising | 13% | — | |||||||
| pulmonary tuberculosis | — | 31% | |||||||
| remission | 12% | — | |||||||
| corneal precipitates | — | 31% | |||||||
| myeloid metaplasia | 12% | — | |||||||
| blurred vision | — | 29% | |||||||
| gout | 11% | — | |||||||
| uveit | — | 27% | |||||||
| hemoglobin increased | 10% | — | |||||||
| shroud | — | 27% | |||||||
| impaired spleen function | 10% | — | |||||||
| papules | — | 26% | |||||||
| change in appetite | 10% | — | |||||||
| eye sensitivity | — | 26% | |||||||
| high temperature | 10% | — | |||||||
| nonspecific allergy | — | 25% | |||||||
| increased ESR | 9% | — | |||||||
| tendency to allergies | — | 25% | |||||||
| weight change | 9% | — | |||||||
| allergy eyes | — | 25% | |||||||
| positive | 9% | — | |||||||
| s eyes cloudy | — | 24% | |||||||
| lung removed | 9% | — | |||||||
| allergy | 7% | 31% | |||||||
| blood diseases | 9% | — | |||||||
| disseminated tuberculosis | — | 24% | |||||||
| neutrophilosis | 9% | — | |||||||
| focal pulmonary tuberculosis | — | 23% | |||||||
| subfebrility | 9% | — | |||||||
| pain in the eyes | — | 23% | |||||||
| aching joints | 9% | — | |||||||
| retinal laser coagulation | — | 23% | |||||||
| electrolyte balance disorders | 9% | — | |||||||
| weak hazy vision | — | 22% | |||||||
| chronic condition | 8% | — | |||||||
| gray eyes | — | 22% | |||||||
| anemia | 8% | — | |||||||
| progressive myopia | — | 22% | |||||||
| emaciation | 8% | — | |||||||
| tumors of the choroid | — | 21% | |||||||
| rapid weight loss | 8% | — | |||||||
| flies in front of the eyes | — | 21% | |||||||
| radiation damage | 8% | — | |||||||
| history of surgery | 6% | 27% | |||||||
| increased bleeding | 8% | — | |||||||
| tuberculosis of lymph nodes | — | 20% | |||||||
| general weakness | 8% | — | |||||||
| chorioretinitis | — | 20% | |||||||
| state of exacerbation | 8% | — | |||||||
| heaviness in the eyes | — | 20% | |||||||
| high fever | 8% | — | |||||||
| conjunctivitis | — | 19% | |||||||
| is better in nature | 8% | — | |||||||
| cry when complaining | — | 19% | |||||||
| thrombocytopenia | 8% | — | |||||||
| lacrimation | — | 19% | |||||||
| a history of organ transplantation | 8% | — | |||||||
| myopia | — | 19% | |||||||
| sweating is increased | 8% | — | |||||||
| acute allergic reactions | — | 19% | |||||||
| stage of recovery | 7% | — | |||||||
| slow onset of the disease | — | 19% | |||||||
| feeling of heat | 7% | — | |||||||
| allergic swelling | — | 19% | |||||||
| patient's condition | 6% | — | |||||||
| crying during complaints | — | 19% | |||||||
| photophobia | — | 18% | |||||||
| increased calcium | — | 18% | |||||||
| glaucoma | — | 18% | |||||||
| increased sensitivity | 7% | 25% | |||||||
| allergy to medications | — | 17% | |||||||
| metastases | — | 16% | |||||||
| vascular tumor | — | 15% | |||||||
| skin anesthesia | — | 15% | |||||||
| intoxication | — | 14% | |||||||
| subacute condition | — | 14% | |||||||
| impaired venous function | — | 14% | |||||||
| calcium | — | 14% | |||||||
| anesthesia | — | 14% | |||||||
| necrosis | — | 14% | |||||||
| damage to the nervous system | — | 13% | |||||||
| basophilia | 14% | 27% | |||||||
| swelling | — | 13% | |||||||
| onset of illness | — | 13% | |||||||
| drug allergy | 8% | 21% | |||||||
| skin problems | — | 13% | |||||||
| drug disease | — | 13% | |||||||
| lowered | — | 12% | |||||||
| increased | 12% | 24% | |||||||
| monocytosis | 12% | 23% | |||||||
| eosinophilia | 10% | 20% | |||||||
| oncology | 9% | 18% | |||||||
| there are no complaints | 10% | 19% | |||||||
| impaired lung function | 7% | 14% | |||||||
| acute condition | 7% | 14% | |||||||
Instructions
Video
|